Analysen zu Novo Nordisk
| 29.04.24 | Novo Nordisk Neutral | UBS AG | |
| 25.04.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | Novo Nordisk Outperform | Bernstein Research | |
| 26.03.24 | Novo Nordisk Neutral | UBS AG | |
| 25.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 18.03.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 11.03.24 | Novo Nordisk Neutral | UBS AG | |
| 08.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.03.24 | Novo Nordisk Overweight | Barclays Capital | |
| 06.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.03.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.03.24 | Novo Nordisk Neutral | UBS AG | |
| 01.03.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.02.24 | Novo Nordisk Neutral | UBS AG | |
| 27.02.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 14.02.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 05.02.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Novo Nordisk Neutral | UBS AG | |
| 01.02.24 | Novo Nordisk Halten | DZ BANK | |
| 01.02.24 | Novo Nordisk Overweight | Barclays Capital | |
| 01.02.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 31.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Novo Nordisk Neutral | UBS AG | |
| 31.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 30.01.24 | Novo Nordisk Neutral | UBS AG | |
| 24.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.24 | Novo Nordisk Overweight | Barclays Capital | |
| 16.01.24 | Novo Nordisk Buy | Jefferies & Company Inc. | |
| 15.01.24 | Novo Nordisk Neutral | UBS AG | |
| 12.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 10.01.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.01.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 18.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.12.23 | Novo Nordisk Overweight | Barclays Capital | |
| 15.12.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 08.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.12.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 05.12.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 21.05.25 | Alphabet A Buy | Jefferies & Company Inc. | |
| 21.05.25 | Alphabet C Kaufen | DZ BANK | |
| 21.05.25 | Stabilus Outperform | Bernstein Research | |
| 21.05.25 | Aroundtown Add | Baader Bank | |
| 21.05.25 | Pfizer Buy | Jefferies & Company Inc. | |
| 21.05.25 | Diageo Overweight | Barclays Capital | |
| 21.05.25 | Saint-Gobain Overweight | JP Morgan Chase & Co. | |
| 21.05.25 | Heidelberg Materials Overweight | JP Morgan Chase & Co. | |
| 21.05.25 | Diageo Buy | UBS AG | |
| 21.05.25 | Fresenius Medical Care Buy | Goldman Sachs Group Inc. | |
| 21.05.25 | Alphabet A Overweight | JP Morgan Chase & Co. | |
| 21.05.25 | National Grid Buy | Deutsche Bank AG | |
| 21.05.25 | Münchener Rückversicherungs-Gesellschaft Neutral | Goldman Sachs Group Inc. | |
| 21.05.25 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 21.05.25 | Daimler Truck Neutral | Goldman Sachs Group Inc. | |
| 21.05.25 | LVMH Moet Hennessy Louis Vuitton Outperform | Bernstein Research | |
| 21.05.25 | UniCredit Buy | Goldman Sachs Group Inc. | |
| 21.05.25 | Ryanair Outperform | Bernstein Research | |
| 21.05.25 | Ryanair Buy | UBS AG | |
| 21.05.25 | SFC Energy Buy | Warburg Research | |
| 21.05.25 | Evonik Buy | Warburg Research | |
| 21.05.25 | Intel Hold | Deutsche Bank AG | |
| 21.05.25 | Semperit Kauf | Warburg Research | |
| 21.05.25 | Südzucker Verkaufen | DZ BANK | |
| 21.05.25 | Hennes & Mauritz AB Equal Weight | Barclays Capital | |
| 21.05.25 | Südzucker Underweight | Barclays Capital | |
| 21.05.25 | SFC Energy Buy | Deutsche Bank AG | |
| 21.05.25 | HORNBACH Add | Baader Bank | |
| 21.05.25 | Wienerberger buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.05.25 | UNIQA Insurance Kauf | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.05.25 | Infineon Buy | Warburg Research | |
| 21.05.25 | VINCI Overweight | JP Morgan Chase & Co. | |
| 21.05.25 | Fraport Overweight | JP Morgan Chase & Co. | |
| 21.05.25 | Eckert & Ziegler Hold | Hauck Aufhäuser Lampe Privatbank AG | |
| 21.05.25 | Richemont Sector Perform | RBC Capital Markets | |
| 21.05.25 | UBS Outperform | RBC Capital Markets | |
| 21.05.25 | Daimler Truck Overweight | JP Morgan Chase & Co. | |
| 21.05.25 | Henkel vz. Buy | Deutsche Bank AG | |
| 21.05.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 21.05.25 | Ryanair Outperform | RBC Capital Markets | |
| 21.05.25 | SFC Energy Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.05.25 | Sartorius vz. Sector Perform | RBC Capital Markets | |
| 20.05.25 | VINCI Buy | UBS AG | |
| 20.05.25 | Salesforce Neutral | UBS AG | |
| 20.05.25 | Münchener Rückversicherungs-Gesellschaft Sector Perform | RBC Capital Markets | |
| 20.05.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 20.05.25 | Diageo Buy | Jefferies & Company Inc. | |
| 20.05.25 | VINCI Buy | Jefferies & Company Inc. | |
| 20.05.25 | JPMorgan Chase Buy | UBS AG | |
| 20.05.25 | Vodafone Group Kaufen | DZ BANK |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.